Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 101 related to Feagan: Erythropoietin with iron supplementation to prevent allogeneic blood transfusion.... (0.09 sec) 

Erythropoietin with iron supplementation to prevent allogeneic blood transfusion in total hip …

- annals.org [PDF] 
BG Feagan, CJ Wong, A Kirkley, DWC Johnston … - Annals of internal medicine, 2000 - Am Coll Physicians
Background: The optimum regimen of epoetin alfa for preven- tion of allogeneic
blood transfusion is unknown. Objective: To determine whether a modified regimen
of epoetin alfa reduces allogeneic blood transfusion in patients undergoing ...
Cited by 86 - Related articles - BL Direct - All 7 versions

Erythropoietin is an effective clinical modality for reducing RBC transfusion in joint surgery


K Karkouti, SA McCluskey, L Evans, N … - Canadian journal of anaesthesia, 2005 - cat.inist.fr
Objectif: Les études de l'efficacité du traitement préopératoire à
l'érythropoïétine(TPE) recommandent un dosage programmé difficile à
observer au quotidien. Nous avons donc institué un programme flexible et l' ...
Cited by 19 - Related articles - All 6 versions

[CITATION] Usefulness of erythropoietin and G-CSF during treatment for chronic hepatitis C with pegylated …


P Lebray, A Pichard, C Broissand… - Hepatology, 2002
Cited by 10 - Related articles

[CITATION] Projecting the healthcare burden from hepatitis C in the United States [abstr]


GL Davis, J Albright, S Cook, D Rosenberg - Hepatology, 1998
Cited by 10 - Related articles

[CITATION] Treatment of ribavirin-induced anemia by erythropoietin [abstr]


A Abergel, C Bonny, S Casanova… - Hepatology, 2002
Cited by 10 - Related articles

[CITATION] Cost analysis of untreated anemia in hepatitis C virus (HCV)-infected patients: an employer's …


M Duh, E Moyneur, S Buteau… - Hepatology, 2003
Cited by 10 - Related articles

Treatment of chronic hepatitis C with interferon alpha and ribavirin


A Pariente - Gastroentérologie Clinique et Biologique, 2003 - masson.fr
262 naïve patients were included. Patients were significantly older, had more
severe liver fibrosis, with cirrhosis in 17 percent, but were comparable for
sex, contamination mode and viral genotype with those of the Poynard et al. ...
Cited by 13 - Related articles - Cached - BL Direct - All 3 versions

Managing anemia in patients with chronic kidney disease or cancer: development and role …


SD Scott - Pharmacotherapy, 2002 - PPI
Anemia, defined as an inadequate level of either hemoglobin or red blood cells,
is common in patients with chronic kidney disease (CKD) or cancer, occurring in
80–90% of patients undergoing hemodialysis and over 50% of patients ...
Cited by 12 - Related articles - BL Direct - All 2 versions

[CITATION] Erythropoietin maintains ribavirin dose and sustained virologic response during HCV …


L Senkbeil, J Moss, P Gaglio… - Hepatology, 2003
Cited by 12 - Related articles

Effect of ribavirin, levovirin and viramidine on liver toxicological gene expression in rats


C Fang, P Srivastava, C Lin - Journal of Applied Toxicology, 2003 - interscience.wiley.com
The ribavirin/interferon- combination is currently the standard therapy for
patients with chronic hepatitis C. However, ribavirin causes hemolytic anemia as
a significant side-effect. Levovirin, an l-enantiomer of ribavirin, ...
Cited by 13 - Related articles - BL Direct - All 4 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google